Breast cancer tumor suppressors: A special emphasis on novel protein nischarin

Cancer Research

Volumn 75, Issue 20, 2015, Pages 4252-4259

  Maziveyi, Mazvita ^a   Alahari, Suresh K ^a  

^a LOUISIANA STATE UNIV HLTH SCI C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NISCHARIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; IMIDAZOLINE RECEPTOR; NISCH PROTEIN, HUMAN; SIGNAL PEPTIDE;

AMYGDALOID NUCLEUS; ANXIETY; BREAST CANCER; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DNA METHYLATION; GENE LOCUS; GENE MUTATION; HUMAN; HYPOTENSION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; BRAIN; BREAST NEOPLASMS; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HYPERTENSION; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY;

BRAIN; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERTENSION; IMIDAZOLINE RECEPTORS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84945387294     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1395     Document Type: Review

References (43)

1. Oliveira AM, Ross JS, Fletcher JA. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol 2005;124: S16-28
2. Varma AK, Brown RS, Birrane G, Ladias JA. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 2005; 44:10941-6
3. Zilfou JT, Lowe SW. Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 2009;1:a001883
4. Yu V. Caretaker Brca1: keeping the genome in the straight and narrow. Breast Cancer Res 2000;2:82-5
5. Deng CX, Scott F. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 2000;19: 1059-64
6. Alahari SK, Reddig PJ, Juliano RL. The integrin-binding protein Nischarin regulates cell migration by inhibiting PAK. EMBO J 2004;23:2777-88
7. Alahari SK, Nasrallah H. A membrane proximal region of the integrin alpha5 subunit is important for its interaction with nischarin. Biochem J 2004;377:449-57
8. Ding Y, Milosavljevic T, Alahari SK. Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion. Mol Cell Biol 2008; 28:3742-56
9. Piletz JE, Deleersnijder W, Roth BL, Ernsberger P, Zhu H, Ziegler D. IRAS splice variants. Ann N Y Acad Sci 2003;1009:419-26
10. Alahari SK, Lee JW, Juliano RL. Nischarin, a novel protein that interacts with the integrin alpha5 subunit and inhibits cell migration. J Cell Biol 2000;151:1141-54
11. Gene Cards. Nisch Gene 2015 [cited 2015 Jul 16]. Available from: http://www.genecards.org/cgi-bin/carddisp.pl?gene=NISCH.
12. Baranwal S, Wang Y, Rathinam R, Lee J, Jin L, McGoey R, et al. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer. J Natl Cancer Inst 2011;103:1513-28
13. Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, et al. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res 2010; 16:3463-72
14. Dontenwill M, Pascal G, Piletz JE, Chen M, Baldwin J, Ronde P, et al. IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells. Cell Death Differ 2003;10:933-5
15. Keller B, Garcia-Sevilla JA. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: effects of treatments with I1-And I2-imidazoline drugs. J Psychopharmacol 2015:1-17
16. NCBI. NISCH 2015 [cited 2015 Jul 16]. Available from: http://www.ncbi. nlm.nih.gov/gene/11188
17. UniProt. Q80TM9 (Nisch-Mouse) 2015 [cited 2015 Jul 16]. Available from: http://www.uniprot.org/uniprot/Q80TM9
18. UniProt. Q9Y2I1 2015 [cited 2015 Jul 16]. Available from: http://www. uniprot.org/uniprot/Q9Y2I1
19. Lim KP, Hong W. Human Nischarin/imidazoline receptor antiseraselected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region. J Biol Chem 2004;279: 54770-82
20. Jain P, Baranwal S, Dong S, Struckhoff AP, Worthylake RA, Alahari SK. Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells. J Biol Chem 2013;288:15495-509
21. Kuijl C, Pilli M, Alahari SK, Janssen H, Khoo PS, Ervin KE, et al. Rac and Rab GTPases dual effector Nischarin regulates vesicle maturation to facilitate survival of intracellular bacteria. EMBO J 2013;32:713-27
22. Sano H, Liu SC, Lane WS, Piletz JE, Lienhard GE. Insulin receptor substrate 4 associates with the protein IRAS. J Biol Chem 2002;277: 19439-47
23. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028-32
24. Smith CM, Finger JH, Hayamizu TF, McCright IJ, Xu J, Berghout J, et al. The mouse Gene Expression Database (GXD): 2014 update. Nucleic Acids Res 2014;42:D818-24
25. Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med 2014;20:1242-53
26. Phosphositeplus. NISCH (human) 2015 [cited 2015 Jul 16]. Available from: http://www.phosphosite.org/proteinAction.do?id=15675& showAllSites=true.
27. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009;325:834-40
28. Czech MP, Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Chem 1999;274:1865-8
29. Kawasome H, Papst P, Webb S, Keller GM, Johnson GL, Gelfand EW, et al. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc Natl Acad Sci U S A 1998;95:5033-8
30. Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J, et al. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 2005;24:6465-81
31. Ding Y, Zhang R, Zhang K, Lv X, Chen Y, Li A, et al. Nischarin is differentially expressed in rat brain and regulates neuronal migration. PLoSONE2013;8: e54563
32. Wu X, Xu W, Cui G, Yan Y, Wu X, Li L, et al. The expression pattern of Nischarin after lipopolysaccharides (LPS)-induced neuroinflammation in rats brain cortex. Inflamm Res 2013;62:929-40
33. Koks S, Luuk H, Nelovkov A, Areda T, Vasar E. A screen for genes induced in the amygdaloid area during cat odor exposure. Genes Brain Behav 2004;3:80-9
34. Zhang J, Abdel-Rahman AA. Inhibition of nischarin expression attenuates rilmenidine-evoked hypotension and phosphorylated extracellular signalregulated kinase 1/2 production in the rostral ventrolateral medulla of rats. J Pharmacol Exp Ther 2008;324:72-8
35. Li J, He X, Dong R, Wang Y, Yu J, Qiu H. Frequent loss of NISCH promotes tumor proliferation and invasion in ovarian cancer via inhibiting the FAK signal pathway. Mol Cancer Ther 2015;14:1202-12
36. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1
37. Chen J, Feng WL, Mo WJ, Ding XW, Xie SN. Expression of integrin-binding protein Nischarin in metastatic breast cancer. Mol Med Rep 2015;12: 77-82
38. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 2009;9:563-75
39. Gastonguay A, Berg T, Hauser AD, Schuld N, Lorimer E, Williams CL. The role of Rac1 in the regulation of NF-kappaB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biol Ther 2012;13:647-56
40. Reddig PJ, Xu D, Juliano RL. Regulation of p21-Activated kinase-independent Rac1 signal transduction by nischarin. J Biol Chem 20053;280: 30994-1002
41. Alahari SK. Nischarin inhibits Rac induced migration and invasion of epithelial cells by affecting signaling cascades involving PAK. Exp Cell Res 2003;288:415-24
42. Dontenwill M, Piletz JE, Chen M, Baldwin J, Pascal G, Ronde P, et al. IRAS is an anti-Apoptotic protein. Ann N Y Acad Sci 2003;1009: 400-12
43. Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des 2013;81:136-47.